Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

852 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Completed

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

NCT01602419

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • University of Utah Salt Lake City, Utah, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View all 24 locations
View Trial Details
Completed

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Octapharma Research Site Sacramento, California, United States
  • Octapharma Research Site Aurora, Colorado, United States
  • Octapharma Research Site Washington D.C., District of Columbia, United States
  • Octapharma Research Site Miami, Florida, United States
View all 30 locations
View Trial Details
Completed

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

NCT02954575

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Specialized Hospital for Active Treatment "Joan Pavel" Sofia, Bulgaria
  • National Haemophilia Centre Budapest, Hungary
  • Krakowskie Centrum Medyczne Krakow, Poland
  • Korczowski Bartosz Gabinet Lekarski Rzeszów, Poland
View Trial Details
Completed

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

NCT03376516

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Kirov SSC Hematology and Transfusiology Kirov, Russia
  • "National Children's Specialized Clinic "OKHMATDYT" Kyiv, Ukraine
  • "Western Ukrainian Specialized Children's Medical Center" Lviv, Ukraine
View Trial Details
Completed

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UC Davis Sacramento, California, United States
  • All Children's Hospital St. Petersburg, Florida, United States
  • Harvard Children's Hospital Boston Boston, Massachusetts, United States
  • Republican Scientific Practical Center for Pediatric Oncology and Hematology Minsk, Belarus
View all 37 locations
View Trial Details
Completed

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

NCT01992549

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UC Davis Medical Center Sacramento, California, United States
  • University of Alberta Edmonton, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • McMaster Children's Hospital Hamilton, Ontario, Canada
View all 15 locations
View Trial Details
Completed

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

NCT01181128

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Sacramento, California, United States
View all 64 locations
View Trial Details

Related conditions